Refine
Year of publication
Document Type
- Preprint (671)
- Article (443)
- Conference Proceeding (1)
- Working Paper (1)
Language
- English (1116) (remove)
Has Fulltext
- yes (1116)
Is part of the Bibliography
- no (1116)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- SARS-CoV-2 (8)
- Heavy-ion collision (6)
- COVID19-NMR (5)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- Solution NMR spectroscopy (4)
- 5′-UTR (3)
- ALICE (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- RNA (3)
- pp collisions (3)
- ACLF (2)
- BCR/ABL (2)
- Beauty production (2)
- Charm physics (2)
- Diagnostic imaging (2)
- Epilepsy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Magnetic resonance imaging (2)
- NMR spectroscopy (2)
- Non-structural protein (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Philadelphia chromosome (2)
- Positron emission tomography (2)
- QCD (2)
- Seizure (2)
- Single electrons (2)
- Solution NMR-spectroscopy (2)
- Vasculitis (2)
- acute-on-chronic liver failure (2)
- glioblastoma (2)
- proteomics (2)
- radiotherapy (2)
- 19F (1)
- 2-deoxyglucose (2-DG) (1)
- 5'-UTR (1)
- 5_SL4 (1)
- 900 GeV (1)
- ALICE detector (1)
- ALK-rearranged NSCLC (1)
- Abl kinase inhibitors (1)
- Active middle ear implants (1)
- Allosteric inhibition (1)
- Alternating Phase Focusing (1)
- Angiomyolipoma (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Anticonvulsant (1)
- Auditory system (1)
- Autologous stem cell transplantation (1)
- B cell receptor (1)
- B. subtilis (1)
- Bartonella grahamii (1)
- Bartonella henselae (1)
- Bartonella schoenbuchensis (1)
- Beam dynamics simulation (1)
- Beskid Niski Mts (1)
- Biogeochemistry (1)
- Biomarker (1)
- Bone conduction devices (1)
- Boosted Jets (1)
- Brain tumor (1)
- Business strategy in drug development (1)
- CAKUT (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- COVID-19 (1)
- CPTAC (1)
- CRC65 (1)
- Carbon cycle (1)
- Cementation (1)
- Centrality Class (1)
- Centrality Selection (1)
- Ceramic (1)
- Chemical communication (1)
- Chocó rainforest (1)
- Chronic disease (1)
- Collective Flow, (1)
- Communication center (1)
- Comparative genomics (1)
- Comparison with QCD (1)
- Consensus statement (1)
- Continuous wave (1)
- Core marking (1)
- Costs (1)
- Covid19-NMR (1)
- Covid19-nmr (1)
- DNA-PAINT (1)
- Data sharing (1)
- Depression (1)
- Drug screens (1)
- Drug therapy (1)
- E. coli (1)
- Ecosystem ecology (1)
- Ecuador (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Everolimus (1)
- Evolution (1)
- FBS (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Forest ecology (1)
- Functionally-impaired elderly (1)
- Fungi (1)
- Gene expression profiling (1)
- General practice (1)
- Genetics (1)
- Glioma (1)
- HBT (1)
- HOD (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hard Scattering (1)
- Health policy (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ion (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hematology (1)
- High-dose chemotherapy (1)
- High-throughput screening (1)
- Holmes tremor (1)
- Hyperons (1)
- Immunology (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Invertebrates (1)
- Ionisation energy loss (1)
- Ixodes ricinus (1)
- Jet Physics (1)
- Jet Substructure (1)
- Lenalidomide (1)
- Leukemias (1)
- Linear accelerator (1)
- Localized defecation (1)
- MTOR inhibitor (1)
- Macrodomain (1)
- Material budget (1)
- Meriç River (1)
- Microplastic (1)
- Mid-rapidity (1)
- Minimal invasive (1)
- Minimum Bias (1)
- Mixed hearing loss (1)
- Mixture toxicity (1)
- Molecular biology (1)
- Molecular matched therapy (1)
- Molecular medicine (1)
- Molecular modelling (1)
- Molecular profiling (1)
- Molecular therapy (1)
- Mollusks (1)
- Monolithic crown (1)
- Monte Carlo (1)
- Multi-Parton Interactions (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiple myeloma (1)
- Multiple stressors (1)
- NAFL (1)
- NASH (1)
- Neural network (1)
- Neuroscience (1)
- Non-small cell lung cancer (1)
- Nonlinear beam dynamics (1)
- Nuclear modification factor (1)
- Nucleus (1)
- Oncology (1)
- Osimertinib (1)
- PYTHIA (1)
- Pain (1)
- Particle and Resonance Production (1)
- Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (1)
- Pb–Pb (1)
- Physiology (1)
- Plant symbiosis (1)
- Pond snail (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Protein drugability (1)
- Proteins (1)
- Proton (1)
- Proton–proton (1)
- Psychiatric disorders (1)
- Quality of life (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- RNA genome (1)
- RNASolution-state NMR (1)
- RSL curve (1)
- Rapidity Range (1)
- Rehabilitation (1)
- Relapse (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- Rhabdomyoma (1)
- SL1 (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- SLC20A1 (1)
- SPSS (1)
- Second-line treatment (1)
- Self-assessment (1)
- Single muons (1)
- Sociodemographic characteristics (1)
- Strangeness (1)
- Subependymal giant cell astrocytoma (1)
- Surgery (1)
- Systematic Uncertainty (1)
- TP53 mutation status (1)
- TR (1)
- TSC (1)
- Target validation (1)
- Targeted therapy (1)
- Technical data (1)
- Tet-inducible system (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Urban ecology (1)
- Vector Boson Production (1)
- Warburg effect (1)
- Xenon-based gas mixture (1)
- Zirconia (1)
- aboveground biomass (1)
- accessory proteins (1)
- acute coronary syndrome (1)
- acute decompensation (1)
- acute lymphatic leukemia (1)
- adult (1)
- aegean (1)
- aging (1)
- allosteric inhibition (1)
- amplicon sequencing (1)
- antisynthetase antibodies (1)
- antisynthetase syndrome (1)
- archeological sea-level limiting points (1)
- arthritis (1)
- artifacts (1)
- artificial feeding (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- biochemistry (1)
- biodiversity (1)
- biophysics (1)
- bipartite networks (1)
- bladder exstrophy-epispadias complex (1)
- cancer (1)
- cannabidiol (1)
- cannabinoids (1)
- cannabis (1)
- cell-free protein synthesis (1)
- cerebrospinal fluid (1)
- chemotherapy (1)
- chronosequence (1)
- cirrhosis (1)
- clinical trial (1)
- cloacal malformation (1)
- coastal geomorphology (1)
- computed tomography (1)
- copeptin (1)
- dE/dx (1)
- data quality (1)
- deadwood (1)
- decomposition (1)
- detector (1)
- diffusion-weighted magnetic resonance imaging (1)
- doxycycline (1)
- drug response (1)
- dysbiosis (1)
- ectosomes (1)
- electrical resistivity tomography (1)
- electroencephalography (EEG) (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- females (1)
- fluorine (1)
- folding (1)
- foraminifera (1)
- foraminifers (1)
- fragment screening (1)
- fragment-based screening (1)
- functional genetics (1)
- geophysical prospections (1)
- global change (1)
- glycolysis (1)
- guidelines (1)
- habitat destruction (1)
- head-and-neck cancer (1)
- healthy subjects (1)
- heavy ion experiments (1)
- hepatic encephalopathy (1)
- hypoxia-induced cell death (1)
- immunotherapy (1)
- inducible gene expression (1)
- inflammation (1)
- interferon gamma (1)
- interstitial lung disease (1)
- intrinsically disordered region (1)
- isocaloric ketogenic diet (1)
- kidney formation (1)
- kinetics (1)
- land use (1)
- lichen diversity (1)
- lichenized fungi (1)
- liver (1)
- lung cancer (1)
- mTOR inhibitor (1)
- magnetic gradiometry (1)
- magnetic resonance imaging (1)
- mechanical ventilation (1)
- medulloblastoma (1)
- medulloblastoma resection (1)
- meta-stable structures (1)
- metabolic cancer therapy (1)
- metabolic syndromes (1)
- metastasis (1)
- microbes (1)
- microbiome (1)
- micropalaeontology (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- mitochondria (1)
- model psychosis (1)
- modularity (1)
- molecular therapy (1)
- mortality (1)
- multicenter study (1)
- multiplexed immunofluorescence (1)
- myocardial infarction (1)
- myositis (1)
- myxomycete (1)
- neoadjuvant chemoradiotherapy (1)
- neoepitopes (1)
- neurodegeneration (1)
- new records (1)
- newly diagnosed glioblastoma (1)
- nivolumab (1)
- nonstructural proteins (1)
- nymphs (1)
- oral cavity cancer (1)
- palatal tremor (1)
- patient stratification (1)
- portal hypertension (1)
- portosystemic shunt (1)
- posterior fossa masses (1)
- predictive biomarker (1)
- proteins (1)
- pulmonary failure (1)
- quark gluon plasma (1)
- randomized (1)
- rare species (1)
- rct (1)
- reassembly (1)
- registry (1)
- reproducibility (1)
- resilience (1)
- resistance (1)
- respiratory failure (1)
- riboswitches (1)
- rigor (1)
- saprotrophic fungi (1)
- sea-level indicator (1)
- sequential ALK-inhibitor therapy (1)
- specialization (1)
- spectra (1)
- spontaneous portosystemic shunt (1)
- standardization (1)
- structural biology (1)
- structural proteins (1)
- subgrouping (1)
- targeted therapy (1)
- temozolomide (1)
- tetracycline (1)
- tetrahydrocannabinol (1)
- transcription (1)
- transovarial transmission (1)
- transstadial transmission (1)
- trees (1)
- troponin (1)
- tumor metabolism (1)
- tumor-infiltrating lymphocytes (1)
- unmethylated MGMT (1)
- urinary tract development (1)
- vector (1)
- zebrafish development (1)
- “gatekeeper” mutation T315I (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1035)
- Frankfurt Institute for Advanced Studies (FIAS) (958)
- Informatik (925)
- Medizin (50)
- Biowissenschaften (12)
- Biochemie, Chemie und Pharmazie (10)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (9)
- Geowissenschaften (4)
- Biodiversität und Klima Forschungszentrum (BiK-F) (3)
- Georg-Speyer-Haus (3)
The SARS-CoV-2 (SCoV-2) virus is the causative agent of the ongoing COVID-19 pandemic. It contains a positive sense single-stranded RNA genome and belongs to the genus of Betacoronaviruses. The 5′- and 3′-genomic ends of the 30 kb SCoV-2 genome are potential antiviral drug targets. Major parts of these sequences are highly conserved among Betacoronaviruses and contain cis-acting RNA elements that affect RNA translation and replication. The 31 nucleotide (nt) long highly conserved stem-loop 5a (SL5a) is located within the 5′-untranslated region (5′-UTR) important for viral replication. SL5a features a U-rich asymmetric bulge and is capped with a 5′-UUUCGU-3′ hexaloop, which is also found in stem-loop 5b (SL5b). We herein report the extensive 1H, 13C and 15N resonance assignment of SL5a as basis for in-depth structural studies by solution NMR spectroscopy.
The stem-loop (SL1) is the 5'-terminal structural element within the single-stranded SARS-CoV-2 RNA genome. It is formed by nucleotides 7–33 and consists of two short helical segments interrupted by an asymmetric internal loop. This architecture is conserved among Betacoronaviruses. SL1 is present in genomic SARS-CoV-2 RNA as well as in all subgenomic mRNA species produced by the virus during replication, thus representing a ubiquitous cis-regulatory RNA with potential functions at all stages of the viral life cycle. We present here the 1H, 13C and 15N chemical shift assignment of the 29 nucleotides-RNA construct 5_SL1, which denotes the native 27mer SL1 stabilized by an additional terminal G-C base-pair.
Background: Addition of temozolomide (TMZ) to radiotherapy (RT) improves overall survival (OS) in patients with glioblastoma (GBM), but previous studies suggest that patients with tumors harboring an unmethylated MGMT promoter derive minimal benefit. The aim of this open-label, phase III CheckMate 498 study was to evaluate the efficacy of nivolumab (NIVO) + RT compared with TMZ + RT in newly diagnosed GBM with unmethylated MGMT promoter.
Methods: Patients were randomized 1:1 to standard RT (60 Gy) + NIVO (240 mg every 2 weeks for eight cycles, then 480 mg every 4 weeks) or RT + TMZ (75 mg/m2 daily during RT and 150–200 mg/m2/day 5/28 days during maintenance). The primary endpoint was OS.
Results: A total of 560 patients were randomized, 280 to each arm. Median OS (mOS) was 13.4 months (95% CI, 12.6 to 14.3) with NIVO + RT and 14.9 months (95% CI, 13.3 to 16.1) with TMZ + RT (hazard ratio [HR], 1.31; 95% CI, 1.09 to 1.58; P = .0037). Median progression-free survival was 6.0 months (95% CI, 5.7 to 6.2) with NIVO + RT and 6.2 months (95% CI, 5.9 to 6.7) with TMZ + RT (HR, 1.38; 95% CI, 1.15 to 1.65). Response rates were 7.8% (9/116) with NIVO + RT and 7.2% (8/111) with TMZ + RT; grade 3/4 treatment-related adverse event (TRAE) rates were 21.9% and 25.1%, and any-grade serious TRAE rates were 17.3% and 7.6%, respectively.
Conclusions: The study did not meet the primary endpoint of improved OS; TMZ + RT demonstrated a longer mOS than NIVO + RT. No new safety signals were detected with NIVO in this study. The difference between the study treatment arms is consistent with the use of TMZ + RT as the standard of care for GBM.
ClinicalTrials.gov NCT02617589
n this paper we report on the investigation of baryonic resonance production in proton-proton collisions at the kinetic energies of 1.25 GeV and 3.5 GeV, based on data measured with HADES. Exclusive channels npπ+ and ppπ0 as well as ppe+e− were studied simultaneously in the framework of a one-boson exchange model. The resonance cross sections were determined from the one-pion channels for Δ(1232) and N(1440) (1.25 GeV) as well as further Δ and N* resonances up to 2 GeV/c2 for the 3.5 GeV data. The data at 1.25 GeV energy were also analysed within the framework of the partial wave analysis together with the set of several other measurements at lower energies. The obtained solutions provided the evolution of resonance production with the beam energy, showing a sizeable non-resonant contribution but with still dominating contribution of Δ(1232)P33. In the case of 3.5 GeV data, the study of the ppe+e− channel gave the insight on the Dalitz decays of the baryon resonances and, in particular, on the electromagnetic transition form-factors in the time-like region. We show that the assumption of a constant electromagnetic transition form-factors leads to underestimation of the yield in the dielectron invariant mass spectrum below the vector mesons pole. On the other hand, a comparison with various transport models shows the important role of intermediate ρ production, though with a large model dependency. The exclusive channels analysis done by the HADES collaboration provides new stringent restrictions on the parameterizations used in the models.
his contribution aims to give a basic overview of the latest results regarding the production of resonances in different collision systems. The results were extracted from experimental data collected with HADES that is a multipurpose detector located at the GSI Helmholtzzentrum, Darmstadt. The main points discussed here are: the properties of the strange resonances Λ(1405) and Σ(1385), the role of Δ’s as a source of pions in the final state, the production dynamics reflected in form of differential cross sections, and the role of the ϕ meson as a source for K− particles.